Samsung Biologics to buy US facility from GSK for $280m

Samsung Biologics to buy US facility from GSK for $280m

FILE PHOTO: Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe/File Photo

22 December, 2025

GSK samsung biologics

Printed by Unregistered user on Mon, 22 Dec 2025 03:48:02 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

GSK sells $3.35b stake in Unilever's India business

India: HUL buys Horlicks as company completes merger with GSK Consumer

Read more from Rest of Asia

Hillhouse’s Samty launches $500m multifamily asset fund

AnyMind Group to buy Japanese beauty distributor Sun Smile